Key result
Mitral valve repair carries up to ~43% long-term mortality in functional and ischemic MR.
Why the study?
Mitral valve repair is a cornerstone treatment for mitral regurgitation, but outcomes across various etiologies remain incompletely understood.
Does mitral valve repair improve survival and echocardiographic parameters across different mitral regurgitation etiologies?
Cohort (n=911)
No
Does mitral valve repair improve survival and echocardiographic parameters across different mitral regurgitation etiologies?
Answers are grounded in this paper and cite their sources.
Mitral valve repair effectively reduces mitral regurgitation and improves cardiac dimensions, but myocardial recovery (EF and strain) may be delayed or insufficient, particularly in patients with pre-existing myocardial dysfunction.
Introduction: Mitral valve repair is a cornerstone treatment for mitral regurgitation (MR), but outcomes across various etiologies remain incompletely understood. Therefore, this study aimed to comprehensively assess the outcomes of mitral valve repair across different MR etiologies, including primary MR, left ventricle functional MR (LVFMR), ischemic MR, left atrial functional MR (LAFMR), and rheumatic MR, by examining in-hospital, short-term, and medium-term outcomes, as well as the change in cardiac function through echocardiographic parameters and strain analysis. Methods: This retrospective study included 911 patients who underwent mitral valve repair at a single center from 2015 to 2021. Echocardiographic and strain analyses were performed preoperatively and at 6 months post-surgery. Mortality outcomes were assessed at in-hospital and at 6, 12, and 51 months postoperatively. Results: There were significant differences in outcomes across MR etiologies. The primary and rheumatic groups demonstrated the lowest mortality rates, whereas the LVFMR, LAFMR, and ischemic groups exhibited markedly higher mortality, both in the early postoperative period and during long-term follow-up. Echocardiographic analysis showed improvements in cardiac dimensions and volumes, but concurrent declines in myocardial function, particularly in ejection fraction, global longitudinal strain, and left atrial reservoir strain. Discussion: This study highlights the importance of etiology-specific risk stratification. While mitral valve repair effectively reduces MR, myocardial recovery may be delayed or insufficient in certain subgroups, especially those with pre-existing myocardial dysfunction. Tailored therapeutic strategies that address the multifactorial nature of functional and ischemic MR are warranted to improve long-term outcomes.
No takes yet. Share an insight, caveat, or question.
Aslannif et al. (2026) conducted a cohort in Mitral regurgitation (n=911). Mitral valve repair vs. Comparison across MR etiologies was evaluated on All-cause mortality at median 51 months. Long-term mortality after mitral valve repair was highest in LV functional, LA functional, and ischemic MR, and lowest in primary and rheumatic MR.
Synapse has enriched 10 related papers. Consider them for comparative context: